CERTARA COAUTHOR
LIVE

Serial Number

99270220

Owner

Certara USA, Inc.

Attorney

Carrie Webb Olson

First Use Date

Oct 3, 2023

Filing Date

Jul 7, 2025

Add to watchlist:

No watchlists yet
View on USPTO

CERTARA COAUTHOR Trademark

Serial Number: 99270220 • Registration: 8142453

CERTARA COAUTHOR is a trademark filed by Certara USA, Inc. on July 7, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Certara USA, Inc. (25 trademarks)

222 S. Central Ave., Ste 2008

Entity Type: 99

Trademark Details

Filing Date

July 7, 2025

Registration Date

February 17, 2026

First Use Anywhere

October 3, 2023

First Use in Commerce

October 3, 2023

Published for Opposition

December 30, 2025

Goods & Services

Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Software as a service (SAAS) featuring generative artificial intelligence software with pre-trained transformer utilizing a proprietary Electronic Common Technical Document (eCTD) library for collaborative authoring of regulatory and medical writing

Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downloadable computer software for drug development research; Downloadable software for use in analyzing and integrating biomedical, pharmaceutical, and clinical data; Downloadable software using artificial intelligence and machine learning for predictive modeling, data mining, semantic search, and natural language processing in the fields of drug discovery, development, and regulatory submissions

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 17, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 17, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 1, 2025 XAEC
ASSIGNED TO LIE
Nov 30, 2025 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 25, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 25, 2025 CNEA
ASSIGNED TO EXAMINER
Nov 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 7, 2025 MAFR
NEW APPLICATION ENTERED
Jul 7, 2025 NWAP